Skip to main content

Research Repository

Advanced Search

Observational cohort study of changing trends in non-invasive ventilation in very preterm infants and associations with clinical outcomes

Sand, Laura; Szatkowski, Lisa; Kwok, T'ng Chang; Sharkey, Don; Todd, David A; Budge, Helen; Ojha, Shalini

Observational cohort study of changing trends in non-invasive ventilation in very preterm infants and associations with clinical outcomes Thumbnail


Authors

Laura Sand

TNG KWOK Tng.Kwok@nottingham.ac.uk
Clinical Research Fellow in Neonatal Medicine

Profile Image

DON SHARKEY don.sharkey@nottingham.ac.uk
Professor of Neonatal Medicine and Technologies

David A Todd

HELEN BUDGE HELEN.BUDGE@NOTTINGHAM.AC.UK
Professor of Neonatal Medicine

SHALINI OJHA Shalini.Ojha@nottingham.ac.uk
Professor of Neonatal Medicine



Abstract

Objective: To determine the change in non-invasive ventilation (NIV) use over time in infants born at <32 weeks’ gestation and the associated clinical outcomes.

Study design: Retrospective cohort study using routinely recorded data from the National Neonatal Research Database of infants born at <32 weeks admitted to neonatal units in England and Wales from 2010 to 2017.

Results: In 56 537 infants, NIV use increased significantly between 2010 and 2017 (continuous positive airway pressure (CPAP) from 68.5% to 80.2% in 2017 and high flow nasal cannula (HFNC) from 14% to 68%, respectively) (p<0.001)). Use of NIV as the initial mode of respiratory support also increased (CPAP, 21.5%–28.0%; HFNC, 1%–7% (p<0.001)).

HFNC was used earlier, and for longer, in those who received CPAP or mechanical ventilation. HFNC use was associated with decreased odds of death before discharge (adjusted OR (aOR) 0.19, 95% CI 0.17 to 0.22). Infants receiving CPAP but no HFNC died at an earlier median chronological age: CPAP group, 22 (IQR 10–39) days; HFNC group 40 (20–76) days (p<0.001). Among survivors, HFNC use was associated with increased odds of bronchopulmonary dysplasia (BPD) (aOR 2.98, 95% CI 2.81 to 3.15) and other adverse outcomes.

Conclusions: NIV use is increasing, particularly as initial respiratory support. HFNC use has increased significantly with a sevenfold increase soon after birth which was associated with higher rates of BPD. As more infants survive with BPD, we need robust clinical evidence, to improve outcomes with the use of NIV as initial and ongoing respiratory support.

Journal Article Type Article
Acceptance Date Aug 5, 2021
Online Publication Date Aug 19, 2021
Publication Date Mar 1, 2022
Deposit Date Aug 25, 2021
Publicly Available Date Aug 25, 2021
Journal Archives of Disease in Childhood - Fetal and Neonatal Edition
Electronic ISSN 1468-2052
Publisher BMJ
Peer Reviewed Peer Reviewed
Volume 107
Issue 2
Pages 150-155
DOI https://doi.org/10.1136/archdischild-2021-322390
Keywords Obstetrics and Gynaecology; General Medicine; Pediatrics, Perinatology, and Child Health
Public URL https://nottingham-repository.worktribe.com/output/6092122
Publisher URL https://fn.bmj.com/content/early/2021/08/18/archdischild-2021-322390

Files





You might also like



Downloadable Citations